Recent merger settlements further confirm that merger remedies are back and indicate the healthcare industry remains a priority for antitrust enforcers.
In July, we published an alert regarding the resolutions of two merger investigations initiated by the Federal Trade Commission (FTC) and the Department of Justice Antitrust Division (DOJ).[1] We observed a key shift in enforcement policies under the new Trump administration based on
Read More Merger Remedies Are Back in Play: Recent Developments